Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y., & Kawahata, K. (2019). Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus. Intern Med.
Chicago Stili AlıntıHanaoka, Hironari, Harunobu Iida, Tomofumi Kiyokawa, Yukiko Takakuwa, ve Kimito Kawahata. "Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients With Systemic Lupus Erythematosus." Intern Med 2019.
MLA AlıntıHanaoka, Hironari, et al. "Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients With Systemic Lupus Erythematosus." Intern Med 2019.